Published in Biochem Pharmacol on June 23, 2010
Human lipopolysaccharide-binding protein (LBP) and CD14 independently deliver triacylated lipoproteins to Toll-like receptor 1 (TLR1) and TLR2 and enhance formation of the ternary signaling complex. J Biol Chem (2013) 0.96
A synthetic lipid A mimetic modulates human TLR4 activity. ChemMedChem (2011) 0.80
Sesamin Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Inhibition of TLR4 Signaling Pathways. Inflammation (2016) 0.79
Kdo2 -lipid A: structural diversity and impact on immunopharmacology. Biol Rev Camb Philos Soc (2014) 0.78
Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu Rev Immunol (2006) 5.35
Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology (2004) 4.09
The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia. Trends Pharmacol Sci (2009) 3.06
Double-stranded RNA-mediated TLR3 activation is enhanced by CD14. Immunity (2006) 2.51
Isolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations. Proc Natl Acad Sci U S A (2004) 2.43
CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation. Nature (2009) 2.13
The LPS receptor (CD14) links innate immunity with Alzheimer's disease. FASEB J (2003) 1.75
Structural biology of the LPS recognition. Int J Med Microbiol (2007) 1.73
TLR4 as the mammalian endotoxin sensor. Curr Top Microbiol Immunol (2002) 1.65
Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice. Glia (2008) 1.44
Specific high affinity interactions of monomeric endotoxin.protein complexes with Toll-like receptor 4 ectodomain. J Biol Chem (2006) 1.36
CD14 directly binds to triacylated lipopeptides and facilitates recognition of the lipopeptides by the receptor complex of Toll-like receptors 2 and 1 without binding to the complex. Cell Microbiol (2006) 1.33
R-form LPS, the master key to the activation ofTLR4/MD-2-positive cells. Eur J Immunol (2006) 1.27
Binding of lipopeptide to CD14 induces physical proximity of CD14, TLR2 and TLR1. Eur J Immunol (2005) 1.22
Lipopolysaccharide sensing an important factor in the innate immune response to Gram-negative bacterial infections: benefits and hazards of LPS hypersensitivity. Immunobiology (2007) 1.18
An essential role for albumin in the interaction of endotoxin with lipopolysaccharide-binding protein and sCD14 and resultant cell activation. J Biol Chem (2002) 1.16
Transfer of monomeric endotoxin from MD-2 to CD14: characterization and functional consequences. J Biol Chem (2007) 1.04
Endotoxin-binding proteins modulate the susceptibility of bacterial endotoxin to deacylation by acyloxyacyl hydrolase. J Biol Chem (2007) 0.99
Glycolipids and benzylammonium lipids as novel antisepsis agents: synthesis and biological characterization. J Med Chem (2009) 0.95
Evidence of a specific interaction between new synthetic antisepsis agents and CD14. Biochemistry (2009) 0.89
Inhibition of lipid a stimulated activation of human dendritic cells and macrophages by amino and hydroxylamino monosaccharides. Angew Chem Int Ed Engl (2007) 0.83
Interaction between CD14 and LXRbeta genes modulates Alzheimer's disease risk. J Neurol Sci (2007) 0.79
Neutrophil elastase targets virulence factors of enterobacteria. Nature (2002) 2.17
The TLR4 antagonist Eritoran protects mice from lethal influenza infection. Nature (2013) 1.78
Endotoxin responsiveness of human airway epithelia is limited by low expression of MD-2. Am J Physiol Lung Cell Mol Physiol (2004) 1.64
Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice. Glia (2008) 1.44
Multivalent glycoconjugates as anti-pathogenic agents. Chem Soc Rev (2012) 1.41
Metabolism of phosphatidylinositol 4-kinase IIIα-dependent PI4P Is subverted by HCV and is targeted by a 4-anilino quinazoline with antiviral activity. PLoS Pathog (2012) 1.23
Basis for the failure of Francisella tularensis lipopolysaccharide to prime human polymorphonuclear leukocytes. Infect Immun (2006) 1.17
High-mobility group nucleosome-binding protein 1 acts as an alarmin and is critical for lipopolysaccharide-induced immune responses. J Exp Med (2011) 1.12
Exploring the LPS/TLR4 signal pathway with small molecules. Biochem Soc Trans (2010) 1.10
Lipopolysaccharide deacylation by an endogenous lipase controls innate antibody responses to Gram-negative bacteria. Nat Immunol (2005) 1.09
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. Blood (2006) 1.04
Glycoconjugates in cancer therapy. Anticancer Agents Med Chem (2008) 0.99
Host defense functions of proteolytically processed and parent (unprocessed) cathelicidins of rabbit granulocytes. Infect Immun (2002) 0.98
Glycolipids and benzylammonium lipids as novel antisepsis agents: synthesis and biological characterization. J Med Chem (2009) 0.95
First experimental identification of Ras-inhibitor binding interface using a water-soluble Ras ligand. Bioorg Med Chem Lett (2009) 0.94
Chemoselective neoglycosylation. Adv Carbohydr Chem Biochem (2007) 0.93
OmpR-dependent and OmpR-independent responses of Escherichia coli to sublethal attack by the neutrophil bactericidal/permeability increasing protein. Mol Microbiol (2002) 0.92
Chemistry of lipid A: at the heart of innate immunity. Chemistry (2014) 0.91
Evidence of a specific interaction between new synthetic antisepsis agents and CD14. Biochemistry (2009) 0.89
Novel alpha-conotoxins from Conus spurius and the alpha-conotoxin EI share high-affinity potentiation and low-affinity inhibition of nicotinic acetylcholine receptors. FEBS J (2007) 0.89
Hemin and a metabolic derivative coprohemin modulate the TLR4 pathway differently through different molecular targets. Innate Immun (2010) 0.87
Toll-like receptor 4 (TLR4) modulation by synthetic and natural compounds: an update. J Med Chem (2013) 0.86
Purified monomeric ligand.MD-2 complexes reveal molecular and structural requirements for activation and antagonism of TLR4 by Gram-negative bacterial endotoxins. Immunol Res (2014) 0.86
Novel Tn antigen-containing neoglycopeptides: synthesis and evaluation as anti tumor vaccines. Bioorg Med Chem (2002) 0.85
Functional characterization of E. coli LptC: interaction with LPS and a synthetic ligand. Chembiochem (2014) 0.83
A synthetic lipid A mimetic modulates human TLR4 activity. ChemMedChem (2011) 0.80
Uniform lipopolysaccharide (LPS)-loaded magnetic nanoparticles for the investigation of LPS-TLR4 signaling. Angew Chem Int Ed Engl (2010) 0.79
Selective cytotoxicity of a bicyclic Ras inhibitor in cancer cells expressing K-Ras(G13D). Biochem Biophys Res Commun (2009) 0.77
Tuning the nature of the fluorescent state: a substituted polycondensed dye as a case study. Chemistry (2012) 0.77
Maternal and neonatal characteristics of an immigrant population in an Italian hospital. J Matern Fetal Neonatal Med (2010) 0.76
Design and characterization of a new class of inhibitors of ras activation. Ann N Y Acad Sci (2004) 0.76
Glucose-derived Ras pathway inhibitors: evidence of Ras-ligand binding and Ras-GEF (Cdc25) interaction inhibition. Chembiochem (2007) 0.76
Modulation of CD14 and TLR4·MD-2 activities by a synthetic lipid A mimetic. Chembiochem (2013) 0.76
Trehalose- and glucose-derived glycoamphiphiles: small-molecule and nanoparticle Toll-like receptor 4 (TLR4) modulators. J Med Chem (2014) 0.76
Conformational features of a synthetic model of the first extracellular loop of the angiotensin II AT1A receptor. J Pept Sci (2003) 0.75
Design, synthesis, and biological evaluation of levoglucosenone-derived ras activation inhibitors. ChemMedChem (2009) 0.75
Recombinant human erythropoietin in the prevention of late anemia in intrauterine transfused neonates with Rh-isoimmunization. J Pediatr Hematol Oncol (2010) 0.75
Zirconium phosphate/phosphonate multilayered films based on push-pull stilbazolium salt: synthesis, characterization and second harmonic generation. Dalton Trans (2008) 0.75
Bicyclic carbohydrate-derived scaffolds for combinatorial libraries. Bioorg Med Chem (2006) 0.75
The interview with a patient on dialysis: feeling, emotions and fears. G Ital Nefrol (2016) 0.75
Functionalization of oxide surfaces by terpyridine phosphonate ligands: surface reactions and anchoring geometry. Langmuir (2010) 0.75
Structure-activity studies on arylamides and arysulfonamides Ras inhibitors. Curr Cancer Drug Targets (2010) 0.75
Introduction: Forum in immunology on neutrophils. Microbes Infect (2003) 0.75
"Endotoxin, TLR4 signaling and beyond". Mol Immunol (2014) 0.75